Enanta Pharmaceuticals Stock Forecast

Sell candidate since Aug 10, 2026

The Enanta Pharmaceuticals stock price gained 0.290% on the last trading day (Monday, 10th Aug 2026), rising from $13.77 to $13.81. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.54% from a day low at $13.64 to a day high of $13.85. The price has risen in 6 of the last 10 days and is up by 8.48% over the past 2 weeks. Volume fell on the last day by -41 thousand shares and in total, 138 thousand shares were bought and sold for approximately $1.90 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Enanta Pharmaceuticals stock with a 90% probability to be traded between $11.18 and $15.22 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ENTA Signals & Forecast

The Enanta Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $13.29 and $13.57. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -8.60%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

Enanta Pharmaceuticals finds support from accumulated volume at $13.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.210 between high and low, or 1.54%. For the last week, the stock has had daily average volatility of 4.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ENTA) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Enanta Pharmaceuticals to open at $13.77, and during the day (based on 14 day Average True Range), to move between $13.52 and $14.10, which gives a possible trading interval of +/-$0.585 (+/-4.33%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.00 (1.38%) than the support at $13.45 (2.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Enanta Pharmaceuticals stock A Buy?

Enanta Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.040 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $13.77 ( 0.314%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk